24 Results

People

  1. Motzer
    Motzer
  2. Sheinfeld
    Sheinfeld
  3. Bajorin
    Bajorin
  4. Rabbani
    Rabbani
  5. Scher
    Scher
  6. Bosl
    Bosl
  7. Guillem
    Guillem
  8. Halpern
    Halpern
  9. Hudis
    Hudis
  10. Hurria
    Hurria

Groups

  1. Department of Medicine (24)
  2. Solid Tumor Oncology Division (19)
  3. Genitourinary Oncology Service (11)
  4. Surgery (11)
  5. Survivorship Research (10)
  6. Urology (7)
  7. GSK Faculty (6)
  8. Division of Subspecialty Medicine (5)
  9. Population Sciences Research Program (4)
  10. Colorectal Surgery (3)
  1. "Department of Medicine"
  2. "Elsevier Science, Inc."
  3. "2003"
Formats
  1. Journal Article (21)
  2. Meeting Abstract (3)
Groups
  1. Department of Medicine (24)
  2. Solid Tumor Oncology Division (19)
  3. Genitourinary Oncology Service (11)
  4. Surgery (11)
  5. Survivorship Research (10)
  6. Urology (7)

More Groups

People
  1. Robert Motzer (6)
  2. George Bosl (4)
  3. Joel Sheinfeld (4)
  4. Dean Bajorin (3)
  5. Farhang Rabbani (3)
  6. Howard Scher (3)

More People

Years
  1. 2003 (24)
Publications
  1. Urology (6)
  2. Critical Reviews in Oncology/Hematology (4)
  3. Journal of Urology (3)
  4. Journal of the American College of Surgeons (3)
  5. Journal of Investigative Dermatology (2)
  6. Lancet Oncology (2)

More Publications

Publishers
  1. Elsevier Science, Inc. (24)

Results (24)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • In vivo fluorescence confocal microscopy of skin in the transgenic green fluorescent protein mouse
    Meeting Abstract

    Swindle, L.; Moricz, C.; Wolchok, J.; Busam, K.; Halpern, A.
    Journal of Investigative Dermatology (2003)

    Fulltext@MSK | Save
  • Diagnosis, treatment, and management of melanoma in situ by US dermatologists
    Meeting Abstract

    Charles, C. A.; Dusza, S. W.; Marghoob, A. A.; Oliveria, S. A.; Kopf, A.; Rigel, D.; Halpern, A. C.
    Journal of Investigative Dermatology (2003)

    Fulltext@MSK | Save
  • K-ras mutatation is a marker of accelerated metastatic progression in colorectal cancer
    Meeting Abstract

    Nash, G. M.; Gimbel, M.; Nathanson, D.; Zeng, Z. S.; Gerald, W.; Kemeny, N.; Fong, Y. M.; Paty, P.
    Journal of the American College of Surgeons (2003)

    Fulltext@MSK | Save
  • Amifostine and chemoradiation therapy: ASCO responds
    Journal Article

    Schuchter, L.; Meropol, N. J.; Winer, E. P.; Hensley, M. L.; Somerfield, M. R.
    Lancet Oncology (2003)

    Fulltext@MSK | Save
  • Prognostic factors and clinical trials of new agents in patients with metastatic renal cell carcinoma
    Journal Article

    Motzer, R. J.
    Critical Reviews in Oncology/Hematology (2003)

    Fulltext@MSK | Save
  • Optimizing targeted therapy and developing novel outcome measures for patients with advanced prostate cancer at Memorial Sloan-Kettering Cancer Center
    Journal Article

    Morris, M. J.; Scher, H. I.
    Critical Reviews in Oncology/Hematology (2003)

    Fulltext@MSK | Save
  • Killer-cell immunoglobulin-like receptor (KIR): Nomenclature report, 2002
    Journal Article

    Marsh, S. G. E.; Parham, P.; Dupont, B.; Geraghty, D. E.; Trowsdale, J.; Middleton, D.; Vilches, C.; Carrington, M.; Witt, C.; Guethlein, L. A.; more...
    Journal of Immunological Methods (2003)

    Fulltext@MSK | Save
  • Prostate cancer: A dynamic illness with shifting targets
    Journal Article

    Shaffer, D. R.; Scher, H. I.
    Lancet Oncology (2003)

    Fulltext@MSK | Save
  • The camptothecins
    Journal Article

    Pizzolato, J.; Saltz, L. B.
    Lancet (2003)

    Fulltext@MSK | Save
  • Follow-up care of breast cancer survivors
    Journal Article

    Hurria, A.; Hudis, C.
    Critical Reviews in Oncology/Hematology (2003)

    Fulltext@MSK | Save